The NCIRD, Division of Viral Diseases, Epidemiology Branch is projecting to host a 5-year, competitive cooperative agreement starting in FY2016 and having a period of performance lasting September 1, 2016 – August 31, 202 1. This cooperative agreement will fund a network of pediatric medical
credit:
institutions conducting prospective, active surveillance for acute gastroenteritis (AGE) and acute respiratory illnesses (ARI) in inpatient and emergency department clinical settings, and among healthy controls.
Funded activities will provide a principal US pediatric vaccine-preventable (and potentially vaccine preventable) disease surveillance system, to include actively assessing a wide spectrum of AGE, ARI and influenza pathogens, evaluations of vaccine effectiveness for licensed vaccines, burden and natural history of disease for pathogens having upcoming and/or new vaccines, pediatric infectious disease transmission dynamics, vaccination/therapeutic policy and development, vaccine impacts for targeted and vulnerable populations, and socioeconomic and microbiological environments potentially relevant to these public health interventions.